Altium Capital Management LP Avidity Biosciences, Inc. Transaction History

Altium Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$11.18 - $20.5 $1.04 Million - $1.91 Million	-93,000 Reduced 38.27%	150,000 $2.18 Million
Q1 2022 May 16, 2022	BUY	$14.2 - $23.78 $255,600 - $428,040	18,000 Added 8.0%	243,000 $4.49 Million
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $661,024 - $917,644	36,400 Added 19.3%	225,000 $5.54 Million
Q2 2021 Aug 13, 2021	BUY	$19.62 - $29.26 $196,200 - $292,600	10,000 Added 5.6%	188,600 $4.66 Million
Q1 2021 May 06, 2021	BUY	$20.28 - $28.15 $3.62 Million - $5.03 Million	178,600 New	178,600 $3.9 Million

250

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.79B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.